Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics.

[1]  Masahiro Nakamura,et al.  MECHANISM OF THE DRUG INTERACTION BETWEEN VALPROIC ACID AND CARBAPENEM ANTIBIOTICS IN MONKEYS AND RATS , 2004, Drug Metabolism and Disposition.

[2]  G. Biggio,et al.  The effect of cyclopyrrolones on GABAA receptor function is different from that of benzodiazepines , 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3]  C. Nemeroff,et al.  Pharmacology of valproate. , 2003, Psychopharmacology bulletin.

[4]  W. Couet,et al.  Comparative Cerebrospinal Fluid Diffusion of Imipenem and Meropenem in Rats , 2000, The Journal of pharmacy and pharmacology.

[5]  C. Johannessen,et al.  Mechanisms of action of valproate: a commentatory , 2000, Neurochemistry International.

[6]  W. Couet,et al.  Imipenem but not meropenem induces convulsions in DBA/2 mice, unrelated to cerebrospinal fluid concentrations , 2000, Fundamental & clinical pharmacology.

[7]  M. Kim,et al.  Low convulsive activity of a new carbapenem antibiotic, DK-35C, as compared with existing congeners. , 1999, Toxicology.

[8]  Wolfgang Löscher,et al.  Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action , 1999, Progress in Neurobiology.

[9]  H. Naganuma,et al.  Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[10]  T. Hasegawa,et al.  Possible Mechanism by Which the Carbapenem Antibiotic Panipenem Decreases the Concentration of Valproic Acid in Plasma in Rats , 1998, Antimicrobial Agents and Chemotherapy.

[11]  T. Matsuishi,et al.  Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem/betamipron. , 1997, The Journal of antimicrobial chemotherapy.

[12]  K. Nishiki,et al.  Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem/cilastatin and meropenem. , 1995, Toxicology letters.

[13]  K. Nishiki,et al.  Low neurotoxicity of LJC 10,627, a novel 1 beta-methyl carbapenem antibiotic: inhibition of gamma-aminobutyric acidA, benzodiazepine, and glycine receptor binding in relation to lack of central nervous system toxicity in rats , 1993, Antimicrobial Agents and Chemotherapy.

[14]  A. Kurihara,et al.  Neurotoxicity of panipenem/betamipron, a new carbapenem, in rabbits: correlation to concentration in central nervous system. , 1992, Journal of pharmacobio-dynamics.

[15]  R. Barrons,et al.  Populations at Risk for Penicillin-Induced Seizures , 1992, The Annals of pharmacotherapy.

[16]  Y. Shoji,et al.  A comparative study on the convulsant activity of carbapenems and beta-lactams. , 1992, Drugs under experimental and clinical research.

[17]  T. Yoshida,et al.  Comparative study of certain antibiotics on epileptogenic property, including (1Rpi, 5S, 6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl)] thio-6-[(R)-1-hydroxyethyl]-1-methyl-carbapenem-3-carboxylate (LJC10627), a carbapenem antibiotic with broad antimicrobial spectrum. , 1991, Journal of pharmacobio-dynamics.

[18]  J. Semel,et al.  Seizures in Patients Simultaneously Receiving Theophylline and Imipenem or Ciprofloxacin or Metronidazole , 1991, Southern medical journal.

[19]  W. Löscher,et al.  The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models , 1991, Epilepsy Research.

[20]  C. Inderlied,et al.  Imipenem/cilastatin treatment of bacterial meningitis in children , 1991, The Pediatric infectious disease journal.

[21]  G. Nisticó,et al.  Epileptogenic activity of some β-lactam derivatives: Structure-activity relationship , 1989, Neuropharmacology.

[22]  R. Giles,et al.  Meropenem: evidence of lack of proconvulsive tendency in mice. , 1989, The Journal of antimicrobial chemotherapy.

[23]  P. Williams,et al.  Animal model for evaluating the convulsive liability of beta-lactam antibiotics , 1988, Antimicrobial Agents and Chemotherapy.

[24]  Tse Cs,et al.  Seizure-like activity associated with imipenem-cilastatin. , 1987 .

[25]  L. Goldfrank.  Goldfrank's Toxicologic emergencies , 1986 .

[26]  M. Barza.  Imipenem: first of a new class of beta-lactam antibiotics. , 1985, Annals of internal medicine.

[27]  G. Calandra,et al.  Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin. , 1985, The American journal of medicine.

[28]  R. Duma,et al.  Primaxin in the treatment of acute bacterial pneumonia in adults. , 1985, The Journal of antimicrobial chemotherapy.

[29]  C. Kamei,et al.  Epileptogenic Activity of Cephalosporins in Rats and Their Structure‐Activity Relationship , 1983, Epilepsia.

[30]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[31]  R. Slaughter,et al.  Seizures associated with high cerebrospinal fluid concentrations of cefazolin. , 1980, American journal of hospital pharmacy.

[32]  G. Nisticó,et al.  2. Cefazolin: a Valid Model of Experimental Epilepsy? , 1980 .

[33]  R. K. Lim,et al.  A Stereotaxic atlas of the dog`s brain , 1960 .

[34]  T. Haley,et al.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. , 1957, British journal of pharmacology and chemotherapy.